Cart
sales@molnova.com
DW14800
CAS No. 2243709-60-4
DW14800( —— )
Catalog No. M26185 CAS No. 2243709-60-4
DW14800 is an inhibitor of PRMT5 (IC50 = 17 nM), enhances the transcription of HNF4α, and reduces the level of H4R3me2s.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 119 | Get Quote |
|
| 5MG | 205 | Get Quote |
|
| 10MG | 357 | Get Quote |
|
| 25MG | 680 | Get Quote |
|
| 50MG | 897 | Get Quote |
|
| 100MG | 1341 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDW14800
-
NoteResearch use only, not for human use.
-
Brief DescriptionDW14800 is an inhibitor of PRMT5 (IC50 = 17 nM), enhances the transcription of HNF4α, and reduces the level of H4R3me2s.
-
DescriptionDW14800 is an inhibitor of PRMT5 (IC50 = 17 nM), enhances the transcription of HNF4α, and reduces the level of H4R3me2s.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2243709-60-4
-
Formula Weight512.64
-
Molecular FormulaC31H36N4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (195.07 mM)
-
SMILESCN(C)c1ccc(cc1)C(=O)N1CCc2cc(ccc2C1)C(=O)NCC(O)CN1CCc2ccccc2C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Aryal M, Pranatharthiharan P, Muriana PM. Optimization of a Microplate Assay for Generating Listeria Monocytogenes, E. Coli O157:H7, and Salmonella Biofilms and Enzymatic Recovery for Enumeration. Foods. 2019 Nov 2;8(11):541.
molnova catalog
related products
-
Procyanidin B3
Procyanidin B3(B3) is a procyanidin dimer that is widely studied due to its high abundance in the human diet and antioxidant activity.
-
TC-E 5003
TC-E 5003 is a selective inhibitor of PRMT1 with IC50 of 1.5 μM.
-
AS-8351
AS-8351 (NSC 51355) is a small molecule that induces reprogramming of human fetal lung fibroblasts into functional cardiomyocytes.
